Skip to content
MedTech Regulatory Intelligence Digest

Global Regulations Intelligent Report

RegTalk Digest is Arazy Group's curated intelligence digest for medical device, IVD, and SaMD teams. We track framework-level change across 140+ markets, scope-filter the noise, and tell you what to do about it — every week and every month.

140+ countries31 years regulatory expertise5,000+ registration activities
RegTalk Monthly Digest
May 31, 2026
CRITICALEUDAMED four-module mandatory-use takes effect
Why this matters: Unregistered devices risk losing EU market access. Complete Actor Registration now.
CRITICALFDA Human Factors final guidance published
Why this matters: Submissions after Aug 1 must adopt the new HF Submission Category decision point.
STRATEGICMexico NOM-137 labeling standard published
Why this matters: 12-month window opens for label, IFU, and contra-labeling rework.
Why RegTalk Digest

Regulatory intelligence built by operators, not aggregators

Most alerts bury you in headlines. RegTalk filters to what governs your portfolio — then tells you who's impacted and what to do.

Scope-filtered, not noise

Every item is filtered to medical devices, IVDs, SaMD, and drug-device combinations, then tiered CRITICAL or STRATEGIC. No pharma, no cosmetics, no scroll-through.

"Why this matters," every time

We don't just report the rule change. Each item carries an operational read: who's impacted, the action required, and the deadline that drives it.

Global by default

EUDAMED, FDA, COFEPRIS, NMPA, TGA, SFDA and more — grouped by trade bloc so one digest covers the markets your portfolio actually spans.

From the LICENSALE® team

Produced by Arazy Group — 31 years and 5,000+ registration activities across 140 countries, behind LICENSALE® and REGISLATE®.

Two cadences

Weekly for execution.

Monthly for strategy.

Subscribe to either or both. Same rigor, two altitudes.

Weekly RegTalk Digest

For teams managing active submissions
  • Framework changes & enforcement signals, last 7 days
  • Key upcoming deadlines with days-out countdown
  • Recall, Early Alert & warning-letter cluster watch
  • Tight, action-first format
Most popular

Monthly RegTalk Digest

For RA/QA leadership & strategic planning
  • Everything in Weekly, synthesized for the month
  • This Month's Synthesis + Macro-Trend Watch
  • Cross-jurisdictional pattern analysis
  • Forward 6–12 month outlook per trend
What's inside every issue

A consistent, decision-ready structure

Open it and go straight to what changed and what it means — no reformatting between issues.

01 · Synthesis

The period's patterns, distilled to 4–5 load-bearing takeaways.

02 · Intelligence Detail

Item-by-item by jurisdiction, tagged CRITICAL / STRATEGIC.

03 · Upcoming Deadlines

Date, jurisdiction, who's impacted, action required.

04 · Macro-Trend Watch

Durable cross-market themes with a 6–12 month outlook.

Optional upgrade

Need it scoped to your portfolio?

Tell us your device categories and target markets. We'll generate a customized regulatory intelligence report covering only the jurisdictions and product types you operate in — same rigor, scoped to your roadmap.

IVDsSaMDEU · EUDAMEDUS · FDAChina · NMPAGCC · SFDA

Select your preferences in the form — no separate request needed.

Product categoriesIVDs, SaMD
Target marketsEU, US, Japan, KSA
CadenceMonthly
Your report scope4 markets · 2 categories
Arazy-Group-Logos-1                                                                    REG Talks Educational
Subscribe

Get RegTalk Digest

Start the standard digest in under a minute. Want it tailored? Add your product and market preferences and we'll scope a custom report.

  • Free standard digest — weekly, monthly, or both
  • Optional custom scoping by product & market
  • Unsubscribe anytime · no legal/regulatory advice

RegTalk Digest is provided for awareness only and is not legal or regulatory advice. We use your details to deliver the digest and, if requested, scope a custom report. Unsubscribe anytime.

MedTech Regulatory Technology · Vancouver, Canada · Since 1995
LICENSALE® · REGISLATE® · 140+ markets
© 2026 Arazy Group. Not legal or regulatory advice.